Incidência e fatores associados à subsíndrome delirium e ao delirium em pacientes com covid-19 em uma Unidade de Terapia Intensiva na cidade de Congonhas-MG
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Introduction: Neurological manifestations associated with Coronavirus disease 19
(covid-19), caused by the coronaviridae SARS-CoV-2 directly or indirectly, are
generally associated with Severe Acute Respiratory Syndrome (SARS) and are
associated with increased severity and morbidity. Disorders of consciousness are
among the most common manifestations in individuals with severe covid-19. Delirium
(DL) and subsyndromal delirium (SSD) are disorders of consciousness that are
associated with longer ICU stay, longer hospitalization, and increased mortality.
However, there are still few studies on DL in individuals with covid-19 admitted to the
ICU, and to date, there are no studies on SSD in this population. In this context, the
present study was developed to evaluate the incidence of SSD and/or DL in patients
admitted to the ICU with covid-19, as well as the sociodemographic, clinical, and
laboratory factors associated with SSD and/or DL. Methods: This is an observational,
longitudinal study conducted in the reference ICU for covid-19 in the city of Congonhas,
Brazil. Between October 20, 2020, and October 20, 2021, all admitted individuals were
screened for SSD and DL twice a day during the entire ICU stay using the Intensive
Care Delirium Screening Checklist (ICDSC). Individuals who presented with SSD
and/or DL were compared with individuals admitted to the ICU with covid-19 who did
not score on the ICDSC. The following factors were evaluated in this comparison: age,
comorbidities, disease severity at ICU admission by the APACHE II scale, laboratory
tests, and clinical outcomes of duration of mechanical ventilation (MV), length of ICU
stay, length of hospitalization, and mortality. Results: Ninety-three patients were
evaluated, of whom 43 (46.7%) presented with SSD and/or DL. The incidence rate was
4.17 cases/100 persons-days. There was no significant difference between the groups
in terms of age and comorbidities. Individuals who presented with SSD and/or DL had
higher disease severity as assessed by the APACHE II score within the first 24 hours
of ICU admission compared to controls (median 16 versus 8 points, p<0.001). SSD
and/or DL were associated with longer ICU and hospital stay (median 19 versus 6
days, p<0.001, and median 22 versus 7 days, p<0.001, respectively). There was no
statistically significant difference in terms of MV duration (p=0.847) and mortality
(p=0.555). Conclusion: Individuals with SSD and/or DL had higher disease severity
and longer ICU and hospital stay compared to individuals without SSD and/or DL. This
study was the first to include individuals with SSD and highlights the importance of
screening for disorders of consciousness to better estimate severity and duration of
ICU and hospital stay, allowing for early treatment measures to be instituted to reduce
hospital costs and increase ICU and hospital bed turnover.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

